Physician

Laertes A Manuelidis, M.D.

According to 2025 Medicare claims, Laertes Manuelidis, M.D. (NPI: 1245220698) practices dermatology in the Cape Coral-Fort Myers, FL market, with the plurality of this provider's patient population coming from Lee, FL. This provider's primary affiliated billing organization is ASSOCIATES IN DERMATOLOGY M D P L (NPI: 1811950371; TIN: 591690361) and primary practice location at 33919-8757.

Manuelidis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 4,945 traditional Medicare patients, billed 45,506 HCPCS/CPT codes, and received $4,088,801 in Medicare payments. The top billing code was 88342 (Special stained specimen slides to examine tissue, initial procedure). Part D data shows 1,696 prescription claims across 657 beneficiaries totaling $428,960 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 49 records totaling $29,241. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $736,754 to $4,088,801. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,935	11,704	$736,754
2016	2,015	12,901	$857,646
2017	2,005	12,572	$859,909
2018	2,058	13,139	$815,756
2019	1,916	14,588	$1,076,413
2020	1,815	19,218	$1,621,660
2021	2,037	22,516	$2,018,619
2022	1,963	33,765	$2,214,942
2023	3,360	46,912	$2,970,444
2024	4,945	45,506	$4,088,801

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	586	1,240	$246,720
2016	605	1,301	$228,942
2017	599	1,269	$254,992
2018	628	1,434	$299,930
2019	614	1,448	$287,483
2020	633	1,581	$127,359
2021	638	1,549	$160,726
2022	649	1,535	$256,342
2023	632	1,635	$299,523
2024	657	1,696	$428,960

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
88342	Special stained specimen slides to examine tissue, initial procedure	570	667	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,623	2,824	$67
88305	Pathology examination of tissue using a microscope, intermediate complexity	3,711	7,105	$48
17000	Destruction of precancer skin growth, 1 growth	913	1,267	$32
17003	Destruction of precancer skin growth, 2-14 growths	541	2,476	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	13	364	$48,083
Xolair	Omalizumab	11	308	$30,264
Clobetasol Propionate	Clobetasol Propionate	142	4,377	$5,851
Clindamycin Phosphate	Clindamycin Phosphate	79	2,684	$3,117
Hydrocortisone	Hydrocortisone	158	4,363	$2,282

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$29,241	SUN PHARMACEUTICAL INDUSTRIES INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Laertes A. Manuelidis, M.D.?

Tedicare shows public-source Medicare data for Laertes A. Manuelidis, M.D. (NPI 1245220698), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laertes A. Manuelidis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Laertes A. Manuelidis, M.D.?

Laertes A. Manuelidis, M.D. is linked to ASSOCIATES IN DERMATOLOGY M D P L (billing NPI 1811950371) in the available physician profile data.

Does Laertes A. Manuelidis, M.D. have Open Payments data?

Laertes A. Manuelidis, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.